Patient Dies During Pfizer Hemophilia Drug Trial
A participant in Pfizer’s long-term clinical study of its hemophilia treatment Hympavzi has died after suffering serious complications, raising concerns about the […]
A participant in Pfizer’s long-term clinical study of its hemophilia treatment Hympavzi has died after suffering serious complications, raising concerns about the […]
Please select your prefered mode of payment.